An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

VRAYLAR®

Drug Information Related Patent

Hold Company

ABBVIE

Dosage and Administration

CAPSULE;ORAL

Specification

EQ 1.5MG BASE; EQ 3MG BASE; EQ 4.5MG BASE; EQ 6MG BASE

Indication

VRAYLAR® is mainly used for adult schizophrenia, bipolar I bipolar disorder and major depressive disorder.

Use

Instructions for Use

API

CARIPRAZINE HYDROCHLORIDE

API Structure

We Supply

Note:

In-house Standard
Facility GMP
Product GMP
DMF in processing

Note:

null

Note:

null

Drug Patent

API Patent

Patent No	Expiration Date
7737142	2029/9/17
7943621	2028/12/16

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Member of

CERTIFICATION